Exhibit 16.1
April 23, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K of Cocrystal Pharma, Inc. dated April 18, 2014. We agree with the statements made concerning our firm contained therein.
Yours very truly,
/s/ Paritz & Company, P.A.
Paritz & Company, P.A.